urothelial cancer
Showing 26 - 48 of 48
A Genotype-Phenotype Urothelial Cancer Registry
Recruiting
- Urothelial Cancer
- +3 more
- saliva sample and questionaire
- saliva sample, questionaire
-
Basking Ridge, New Jersey
- +3 more
Jun 2, 2022
Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)
Recruiting
- Oncology
- +16 more
- E-602
- Pembrolizumab
-
Grand Rapids, Michigan
- +4 more
May 27, 2022
Cervical Cancer, Renal Cancer, Urothelial Cancer Trial run by the NCI (Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood
Completed
- Cervical Cancer
- +4 more
- Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood Lymphocytes (PBL)
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2022
Urothelial Cancer Trial run by the NCI (Bintrafusp alfa (M7824))
Terminated
- Urothelial Cancer
- Bintrafusp alfa (M7824)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 25, 2022
Urothelial Cancer, Metastatic Solid Tumor Trial in New York (Colchicine)
Recruiting
- Urothelial Cancer
- Metastatic Solid Tumor
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Mar 5, 2022
Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),
Recruiting
- Melanoma
- +7 more
- Nivolumab or Pembrolizumab (dependent upon approved indication)
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Feb 10, 2022
Urothelial Cancer Trial in Spain (Niraparib plus Cabozantinib)
Recruiting
- Urothelial Cancer
- Niraparib plus Cabozantinib
-
Barcelona, Cataluña, Spain
- +10 more
Feb 8, 2022
Urothelial Cancer Trial in Dallas (Stereotactic Ablative Radiation)
Terminated
- Urothelial Cancer
- Stereotactic Ablative Radiation
-
Dallas, TexasAurelie Garant
Jun 10, 2021
Urothelial Cancer Trial in Australia, Canada (Nab-Paclitaxel, Paclitaxel)
Completed
- Urothelial Cancer
-
Douglas, Queensland, Australia
- +36 more
Oct 28, 2020
Urothelial Cancer Trial in Philadelphia (PEMBROLIZUMAB, hypofractionated radiation)
Withdrawn
- Urothelial Cancer
- PEMBROLIZUMAB
- hypofractionated radiation
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 22, 2019
Neoadjuvant Cisplatin-based Chemotherapy in Urothelial Cancer
Completed
- Urothelial Cancer
-
Chicago, IllinoisUniversity of Chicago
May 1, 2018
Non Small Cell Lung Cancer, Advanced Triple Negative Breast Cancer, Small Cell Lung Cancer Trial (Pembrolizumab, CDX-1401,
Withdrawn
- Non Small Cell Lung Cancer
- +5 more
- Pembrolizumab
- +2 more
- (no location specified)
Dec 5, 2016
Urothelial Cancer Trial in United States (Gemcitabine, Cisplatin, Sunitinib)
Completed
- Urothelial Cancer
- Gemcitabine, Cisplatin, Sunitinib
-
Tucson, Arizona
- +47 more
Sep 15, 2016
Urothelial Cancer Trial in Suresnes (Everolimus (Afinitor®))
Completed
- Urothelial Cancer
- Everolimus (Afinitor®)
-
Suresnes, Ile de France, FranceHôpital FOCH
Jun 20, 2016
Urothelial Cancer, Bladder Cancer Trial in Ann Arbor, Rochester, Portland (Neoadjuvant Cisplatin and Gemcitabine)
Terminated
- Urothelial Cancer
- Bladder Cancer
- Neoadjuvant Cisplatin and Gemcitabine
-
Ann Arbor, Michigan
- +2 more
Nov 4, 2015
Urothelial Cancer, Bladder Cancer Trial in Ann Arbor (ABI-007 (Abraxane®))
Terminated
- Urothelial Cancer
- Bladder Cancer
- ABI-007 (Abraxane®)
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Aug 28, 2015
Urothelial Cancer, Bladder Cancer Trial in Ann Arbor (Lapatinib and Paclitaxel)
Withdrawn
- Urothelial Cancer
- Bladder Cancer
- Lapatinib and Paclitaxel
-
Ann Arbor, MichiganUniversity of Michigan
Jan 15, 2013